Welcome to our dedicated page for Ufp Technologies news (Ticker: UFPT), a resource for investors and traders seeking the latest updates and insights on Ufp Technologies stock.
UFP Technologies, Inc. (UFPT) delivers innovative custom-engineered solutions for medical device manufacturers and industrial partners through advanced material science and precision manufacturing. This news hub provides investors and industry professionals with direct access to UFPT's official announcements and strategic developments.
Track all corporate communications including quarterly earnings, product innovation launches, and strategic partnerships. Our curated collection features regulatory filings, manufacturing process advancements, and market expansion updates essential for understanding UFPT's position in specialty packaging and component manufacturing.
Key updates cover medical sector innovations, new material applications, and OEM collaboration milestones. Stay informed about UFPT's patented technologies and engineering capabilities that drive solutions for minimally invasive surgery, implant packaging, and aerospace components.
Bookmark this page for real-time updates on UFPT's operational developments and industry leadership. Regularly refreshed content ensures you maintain current awareness of this critical supply chain partner's evolving market role.
UFP Technologies (Nasdaq: UFPT) reported outstanding Q2 2025 results with significant growth across key metrics. Net income reached $17.2 million ($2.21 per diluted share), up from $13.6 million in Q2 2024. Sales surged 37.2% to $151.2 million, driven by acquisitions and 5% organic growth.
The company's MedTech business grew 46% while Advanced Components declined 20%. During Q2, UFPT completed two strategic acquisitions: Universal Plastics & Engineering (UNIPEC) and Techno Plastics Industries (TPI), enhancing capabilities in specialty film components and medical device thermoplastic molding. Despite facing $1.2 million in temporary labor costs at the AJR facility, gross margins remained strong at 28.8%.
Year-to-date performance showed continued strength with sales up 39.1% to $299.3 million and adjusted EBITDA increasing 39.1% to $62.1 million.
UFP Technologies (NASDAQ: UFPT), a contract development and manufacturing organization focused on medical devices, will release its second quarter 2025 financial results on August 4, 2025 after market close.
The company will host a conference call to discuss the results on August 5, 2025, at 8:30 AM ET. Investors can access the call via toll-free (1-888-243-4451) or international (1-412-542-4135) numbers. A live webcast and accompanying materials will be available at www.ufpt.com, with a replay accessible afterward on the company's Investor Relations website.
UFP Technologies (NASDAQ:UFPT) has acquired Universal Plastics & Engineering Company (UNIPEC), a Maryland-based manufacturer of precision thermoformed and heat-sealed polymer components for medical devices. UNIPEC specializes in producing components for battery shielding in Class III implantable medical devices.
The acquisition strengthens UFP Technologies' presence in the medical manufacturing sector. UNIPEC, a family-owned business since 1957, brings valuable capabilities and customer relationships to UFP's expanding medical-focused portfolio. Trout Capital Advisors served as the exclusive financial advisor to UNIPEC in this transaction.
UFP Technologies (NASDAQ:UFPT) has announced two strategic acquisitions to enhance its medical device manufacturing capabilities: Universal Plastics & Engineering Company (UNIPEC) and Techno Plastics Industries (TPI).
UNIPEC, based in Maryland, specializes in precision thermoformed and heat-sealed polymer components for Class III implantable medical devices, with $5 million in revenue and $2 million in EBITDA. TPI, located in Puerto Rico, focuses on precision thermoplastic injection-molded components, generating $10 million in revenue and $1 million in EBITDA.
The acquisitions strengthen UFP's capabilities in tight tolerance film components and thermoplastic molding, particularly complementing their Welch Fluorocarbon operation and DAS business in the Dominican Republic. The deals were funded through available cash and existing credit facilities.
UFP Technologies (NASDAQ:UFPT) has announced its participation in the CJS Securities 25th Annual Summer Conference. Mitchell Rock, President, and Ron Lataille, Senior Vice President & CFO, will deliver a presentation and conduct one-on-one investor meetings at the event scheduled for Thursday, July 10, 2025.
UFP Technologies (NASDAQ: UFPT), a designer and manufacturer of medical device components and sterile packaging solutions, has scheduled its first quarter 2025 financial results announcement for May 6, 2025, before market opening.
The company will host a conference call at 10:00 AM Eastern Time on the same day to discuss the Q1 2025 results. Investors can join through:
- Toll-Free: 1-888-243-4451
- International: 1-412-542-4135
A live webcast will be available at www.ufpt.com, with a replay accessible afterward on the company's Investor Relations website at ufpt.com/investors/.
UFP Technologies (Nasdaq: UFPT), a specialized manufacturer focusing on medical market components and packaging, has announced its participation in the upcoming KeyBanc Capital Markets Healthcare Forum. The virtual event will feature presentations from the company's leadership, including Chairman and CEO R. Jeffrey Bailly and CFO Ron Lataille, scheduled for March 18, 2025, at 10:30 AM ET.
FAQ
What is the current stock price of Ufp Technologies (UFPT)?
What is the market cap of Ufp Technologies (UFPT)?
